Product Information
METOCLOPRAMIDE 5 MG/5 ML SOLN is a generic product labeled by Chartwell RX LLC, priced at $0.1257 per ML under NDC 62135052647. Its NADAC has been published 153 times since Nov 1, 2023.
FDA first approved this application on Oct 27, 1992.
Strength
5 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135052647
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073680FDA Approved
10/27/1992
On Market Since
10/27/1992
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG/5 ML SOLN has been published 153 times since Nov 1, 2023, and over the history we have for it it has risen 208.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1257 per ML |
|---|---|
| All-time high | $0.1315 (Jan 14, 2026) |
| All-time low | $0.0297 (May 22, 2024) |
| 52-week high | $0.1315 |
| 52-week low | $0.1101 |
| Median price | $0.0401 |
| Average price | $0.0717 |
| Largest weekly change | +33.3% (Jul 23, 2025) |
| Weeks tracked | 153 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoclopramide hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dopamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG/5 ML SOLN, manufactured by Chartwell RX LLC, is $0.1257 per ML (NDC 62135052647), effective Sep 30, 2026.
How has the price of METOCLOPRAMIDE 5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG/5 ML SOLN has risen 208.6%. It has been tracked across 153 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG/5 ML SOLN?
Since Nov 1, 2023, the NADAC for METOCLOPRAMIDE 5 MG/5 ML SOLN has ranged from a low of $0.0297 (May 22, 2024) to a high of $0.1315 (Jan 14, 2026), with a median of $0.0401 per ML.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG/5 ML SOLN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 5 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 5 MG/5 ML SOLN?
METOCLOPRAMIDE 5 MG/5 ML SOLN (NDC 62135052647) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.